Christopher B Anderson, MD

Christopher B Anderson, MD Specialties: Urology, Urologic Oncology

Christopher B Anderson, MD
Specialties: Urology, Urologic Oncology
phone icon
checkmark iconAccepting new patients


CUIMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Other Locations

Additional Locations for Christopher B Anderson, MD

insurance iconinsurance icon
Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • Affinity Health Plan
  • AgeWell
  • Amida Care
  • Emblem/GHI
  • Emblem/Hip
  • Empire Blue Cross Blue Shield Healthplus
  • Empire Blue Cross/Blue Shield
  • Fidelis Care
  • Healthfirst
  • Local 1199
  • Magnacare (National)
  • Medicare
  • Multiplan
  • MVP Health Care
  • Oxford Health Plans
  • Quality Health Management
  • RiverSpring
  • UnitedHealthcare
  • WellCare

about iconabout icon
About Christopher B Anderson, MD

Christopher B. Anderson, MD, Associate Professor of Urology at CUMC, joined the Department of Urology in September 2015. He specializes in cancers of the bladder, prostate, kidney, testis and penis and performs both open and robotic surgeries. Dr. Anderson completed his medical degree from Northwestern University, completed his urology residency at Vanderbilt University, and then spent two years at Memorial Sloan Kettering Cancer Center as a fellow in urologic oncology. Following his residency, Dr. Anderson completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center and obtained a Master of Public Health degree from Harvard University.

Dr. Anderson's research interests include factors that influence the quality of surgery, access to care for patients with bladder cancer, outcomes after robotic prostatectomy, and active surveillance strategies for men with prostate cancer. Dr. Anderson has published several peer-reviewed articles and was recognized as "Best Reviewer" in 2014 by The Journal of Urology and in 2016 by Cancer.

Dr. Anderson has clinical expertise in robotic prostatectomy for the treatment of prostate cancer, radical cystectomy with orthotopic neobladder for patients with bladder cancer, and partial nephrectomy for the treatment of kidney tumors. He also specializes in the multidisciplinary management of men with testicular cancer, including the use of primary and post-chemotherapy retroperitoneal lymph node dissection. He is currently the site leader for several clinical trials investigating the use of immunotherapy in patients with invasive and non-invasive bladder cancer.

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center


  • Adrenal Cancer

  • Bladder Cancer

  • Cystectomy

  • Cystoscopy

  • Kidney Cancer

  • Laparoscopic Nephrectomy

  • Neobladder

  • Nephrectomy

  • Partial Nephrectomy

  • Prostate Cancer

  • Retroperitoneal Lymph Node Dissection

  • Robotic Partial Nephrectomy

  • Robotic Prostatectomy

  • Robotic Surgery

  • Testicular Cancer

  • Urological Oncology


  • Fellowship: Memorial Sloan Kettering Cancer Center
  • Medical School: Northwestern University - Feinberg School of Medicine
  • Residency: Vanderbilt University Medical Center

Board Certifications

  • Urology